WellPoint Will Cover Merck's Gardasil
July 3, 2006
Health insurance company WellPoint Inc. said Thursday it will cover Merck & Co.'s vaccine that blocks the two types of the STD human papillomavirus (HPV) responsible for about 70 percent of cervical cancers. Earlier on Thursday, CDC's Advisory Committee on Immunization Practices recommended the Gardasil vaccine be routinely given to girls ages 11-12. Health officials estimated that more than half of sexually active women and men will be infected with one or more types of HPV in their lifetime. WellPoint said its decision to cover Gardasil was prompted by the committee's recommendation.
California Supreme Court Rules That Withholding Sexual History Can Be Grounds for Lawsuits Involving HIV Transmission
This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.